CAM
SLXP

Capstone Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Capstone Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,883
Closed -$1.19M – 1680
2015
Q1 		$1.19M Buy
6,883
+302
+5% +$44.3K 0.03% 588
2014
Q4 		$756K Sell
6,581
-1,330
-17% -$161K 0.02% 782
2014
Q3 		$1.24M Sell
7,911
-35
-0.4% -$5.07K 0.04% 492
2014
Q2 		$980K Sell
7,946
-324
-4% -$35.8K 0.03% 624
2014
Q1 		$857K Buy
8,270
+140
+2% +$14.3K 0.03% 685
2013
Q4 		$731K Sell
8,130
-2,724
-25% -$217K 0.02% 829
2013
Q3 		$726K Sell
10,854
-20,200
-65% -$1.39M 0.02% 1015
2013
Q2 		$2.05M Buy
+31,054
New +$1.78M 0.05% 408

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Capstone Asset Management's SLXP Position: Q2 2015 in Review

Capstone Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 6,883 shares — an estimated $1.19M sold.

Capstone Asset Management first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $2.05M in Q2 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Capstone Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Capstone Asset Management sold 6,883 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.19M.
  • Capstone Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Capstone Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $2.05M in Q2 2013.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Capstone Asset Management's 13F filing for Q2 2015, filed 15 Jul 2015.